Healthcare-associated infections – a threat to patient safety in Europe A total of 8.9 million HAIs were estimated to occur each year in European hospitals and long-term care facilities Read more
Antimicrobial use in: Long-term care facilities 3/4 of the prophylaxis courses in long-term care facilities were given to prevent urinary tract infections. This practice is associated with increased antimicrobial resistance. Read more
Antimicrobial use in European hospitals and long-term care facilities 1 in 3 patients received at least one antimicrobial on any given day. Some of this use may be unnecessary and contribute to the spread of antimicrobial resistance. Read more
Antibiotic resistance – an increasing threat to human health Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden is comparable to that of influenza, tuberculosis and HIV/AIDS combined. Read more
We work together to fight antibiotic resistance - Keeping Europeans healthy How do EU agencies contribute to the fight against antimicrobial resistance? See a joint EMA/ECDC/EFSA/EEA infographic Read more
Antibiotikas lieto atbildīgi Infografikā skaidrots, kas ir antibiotiku rezistence, un norādītas problēmas un to apmērs gan slimnīcās, gan sabiedrībā, ko izraisa antibiotiku rezistence un antibiotiku lietošana cilvēkiem. Read more
Ka izplatas antimikroba rezistence? Šajā infografikā skaidrots, kā antibiotiku rezistence izplatās lopkopībā, sabiedrībā, veselības aprūpes iestādēs un ceļojumos. Read more
Rezistence pret antimikrobiāliem līdzekļiem Eiropā: 2014. g. Datu pārskats par rezistenci pret antimikrobiāliem līdzekļiem Eiropā, publicēts 2014. g. Read more
Pieaugoša rezistence pret jaunāko antibiotiku paaudzi: 2013. g. Karbapenēmi ir viena no galvenajām jaunāko antibiotiku klasēm bakteriālo infekciju ārstēšanai. Pret karbapenēmiem rezistentu infekciju izplatīšanās ir drauds Eiropas veselības aprūpei un pacientu drošībai, jo tas nopietni ietekmē iespējas izārstēt infekcijas. Read more
